Nature Communications (Nov 2022)
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents
- Roxane Dumont,
- Viviane Richard,
- Elsa Lorthe,
- Andrea Loizeau,
- Francesco Pennacchio,
- María-Eugenia Zaballa,
- Hélène Baysson,
- Mayssam Nehme,
- Anne Perrin,
- Arnaud G. L’Huillier,
- Laurent Kaiser,
- Rémy P. Barbe,
- Klara M. Posfay-Barbe,
- Silvia Stringhini,
- SEROCoV-KIDS study group,
- Idris Guessous
Affiliations
- Roxane Dumont
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Viviane Richard
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Elsa Lorthe
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Andrea Loizeau
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Francesco Pennacchio
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- María-Eugenia Zaballa
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Hélène Baysson
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- Mayssam Nehme
- Department of Health and Community Medicine, Faculty of Medicine, University of Geneva
- Anne Perrin
- Division of General Pediatrics, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals
- Arnaud G. L’Huillier
- Division of General Pediatrics, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals
- Laurent Kaiser
- Geneva Center for Emerging Viral Diseases and Laboratory Virology, Geneva University Hospitals
- Rémy P. Barbe
- Division of Child and Adolescent Psychiatry, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals
- Klara M. Posfay-Barbe
- Division of General Pediatrics, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals
- Silvia Stringhini
- Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals
- SEROCoV-KIDS study group
- Idris Guessous
- Department of Health and Community Medicine, Faculty of Medicine, University of Geneva
- DOI
- https://doi.org/10.1038/s41467-022-34616-8
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 8
Abstract
The post-acute impacts of COVID-19 in children and adolescents are not well understood. In this population-based study in Geneva, the authors find evidence of COVID-19-related symptom persistence beyond 12 weeks in adolescents, and identify chronic conditions and lower socioeconomic status as risk factors.
